In the BioHarmony Drug Report Database
Pemirolast
Alamast (pemirolast) is a small molecule pharmaceutical. Pemirolast was first approved as Alamast on 1999-09-24. It is used to treat allergic conjunctivitis in the USA.
Trade Name
|
Alamast |
|---|---|
Common Name
|
pemirolast |
ChEMBL ID
|
CHEMBL1201198 |
Indication
|
allergic conjunctivitis |
Drug Class
|
Antiasthmatics/antiallergics (not acting primarily as antihistamines) |
Image (chem structure or protein)